Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

Discovering Factors in the Clinical Trial Journey of Dementia Patients

NCT05850000 ·Status: NOT_YET_RECRUITING

Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome

NCT01112683 ·Status: COMPLETED ·Phase: PHASE4

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

NCT00754013 ·Status: TERMINATED ·Phase: PHASE3

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

NCT00568776 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Clinical Trial Experiences of Alzheimer's Disease Patients

NCT05672732 ·Status: NOT_YET_RECRUITING

Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia

NCT04522739 ·Status: COMPLETED ·Phase: PHASE4

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

NCT00754052 ·Status: TERMINATED ·Phase: PHASE3

A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

NCT05744401 ·Status: TERMINATED ·Phase: PHASE2

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

NCT05552157 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

NCT06647498 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

NCT05602727 ·Status: TERMINATED ·Phase: PHASE2

NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome

NCT07278492 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

NCT02907567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies

NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

NCT02079909 ·Status: COMPLETED ·Phase: PHASE2

A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

NCT05463731 ·Status: COMPLETED ·Phase: PHASE3

BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease

NCT04229927 ·Status: UNKNOWN ·Phase: PHASE3

Ascending Dose Study of CT1812 in Healthy Volunteers

NCT02570997 ·Status: COMPLETED ·Phase: PHASE1

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

NCT00074529 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

NCT01921972 ·Status: COMPLETED ·Phase: PHASE4

Enhancing Consent for Alzheimer's Research

NCT00453544 ·Status: COMPLETED ·Phase: NA

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

NCT01626391 ·Status: TERMINATED ·Phase: PHASE2

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

NCT00939783 ·Status: TERMINATED ·Phase: PHASE3